NCT00442897View on ClinicalTrials.gov

Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease (0653A-126)(COMPLETED)

PHASE4CompletedINTERVENTIONAL

Enrollment

229

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Hypercholesterolemia

Interventions

DRUG

simvastatin (+) ezetimibe

simvastatin (+) ezetimibe 10/20mg, tablet, once daily, 12wks(sub group:24wks)

DRUG

Comparator: atorvastatin

atorvastatin 10mg, tablet, once daily, 12wks(sub group:24wks)

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00442897 - Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease (0653A-126)(COMPLETED) | Biotech Hunter | Biotech Hunter